Introduction {#sec1-1}
============

Keratoprosthesis implantation is performed for a variety of ocular surface disorders including multiple failed penetrating keratoplasties, severe corneal vascularization, chemical injuries with stem cell loss, and autoimmune cicatrizing disorders such as Steven Johnson syndrome.\[[@ref1][@ref2]\] The "Auro K Pro" (Aurolab, Aravind Eye Care System, Chennai) is a keratoprosthesis made in India and is based on the Boston Type 1 keratoprosthesis design.

Although outcomes of keratoprosthesis implantation have improved over the years, complications have not been completely eliminated and include retroprosthetic membranes, persistent epithelial defects, glaucoma, stromal necrosis, infectious keratitis, and endophthalmitis.\[[@ref3][@ref4]\] Fungal infections are being increasingly reported\[[@ref3][@ref4][@ref5][@ref6]\] and have been attributed partly to the prolonged use of broad-spectrum antibiotics and therapeutic contact lenses.\[[@ref5]\] In this communication, we report the clinical course of fungal keratitis and endophthalmitis in a patient implanted with the Auro K Pro.

Case Report {#sec1-2}
===========

A 70-year-old patient presented with corneal vascularization and limbal stem cell deficiency secondary to trachoma in the right eye (OD). He reported having undergone intracapsular cataract extraction 20 years ago OD. Visual acuity was the perception of light (PL+) with accurate projection of rays and intraocular pressure (IOP) was 16 mm of Hg. The left eye (OS) had no perception of light, an opaque, and heavily vascularized cornea and an IOP of 40 mm of Hg. Ultrasonography OD was unremarkable with an axial length of 23.5 mm and no shadow of the crystalline lens or acoustic reverberations from an IOL confirming the aphakic status. Advanced optic nerve head cupping was seen OS. The patient also had fingernail onychomycosis for which he had taken 6 months of antifungal therapy. After obtaining informed consent, primary implantation of an aphakic Auro K Pro (+61.5 dioptres) was done with an initial uncomplicated course \[[Figure 1a](#F1){ref-type="fig"} and [b](#F1){ref-type="fig"}\] on a postoperative regimen of topical vancomycin (5%), moxifloxacin (0.5%), prednisolone acetate (1%), and 1% carboxymethyl cellulose each instilled 6 times/day. The epithelial defect had healed by the 10^th^ postoperative day and the best corrected visual acuity (BCVA) by the end of the 3^rd^ week was 20/80.

![(a) Auro K pro (b) clearly visible posterior pole (c) infiltrates at back of carrier graft 6-weeks postoperatively (d) fluffy deposits on keratoprosthesis stem (e) increasing infiltrates after 3 days of antifungal therapy (f) development of vitritis (g) vitreous tap polymerase chain reaction positive for panfungal genome (h) dotted line represents site of intrastromal injection of amphotericin B for confluent infiltrates (i and j) decreasing infiltrates after intravitreal and intrastromal amphotericin B (k) amniotic membrane graft for nonhealing epithelial defect (l) closed funnel retinal detachment at the last follow-up](OJO-11-62-g001){#F1}

At the 6 weeks\' follow-up, BCVA had decreased to 20/200. Deep stromal infiltrates in the carrier graft \[[Figure 1c](#F1){ref-type="fig"}\], and fluffy deposits on the back of the keratoprosthesis stem, along with a missing bandage contact lens and presence of an epithelial defect were noted \[[Figure 1d](#F1){ref-type="fig"}\]. Considering a clinical diagnosis of fungal keratitis, topical steroids were stopped and topical (G. Amphotericin B 0.15% and G. Natamycin 5% 1 hourly) and systemic antifungals (oral Fluconazole 200 mg twice a day) were started. Three days later, BCVA had deteriorated to 20/400 and infiltrates in the corneal stroma and on the stem of the K Pro optic had increased \[[Figure 1e](#F1){ref-type="fig"}\] along with development of vitritis \[[Figure 1f](#F1){ref-type="fig"}\]. A presumptive diagnosis of fungal endophthalmitis was made, vitreous tap was taken and intravitreal amphotericin B (5 μg/0.1 ml), dexamethasone (400 μg/0.1 ml), and moxifloxacin (500 μg/0.1 ml) injected. The decision to inject intravitreal dexamethasone under cover of antifungal agent was taken based on a beneficial effect of intravitreal dexamethasone in promoting faster clearance of inflammation in fungal endophthalmitis reported previously.\[[@ref7]\] The gram stain, KOH wet mount, and culture from the vitreous sample were negative. Polymerase chain reaction of the vitreous sample was strongly positive for a panfungal genome \[[Figure 1g](#F1){ref-type="fig"}, lane no 2, sample no 537\].

Due to lack of significant resolution of the colonies at back of optic stem and increasing confluence of the corneal infiltrates \[[Figure 1h](#F1){ref-type="fig"}\], amphotericin B 5 μg/0.1 ml was repeated intravitreally after 72 h and was also injected intrastromally into the carrier graft around the edge of the infiltrates \[[Figure 1h](#F1){ref-type="fig"}-dotted line\] after corneal scrapings had been taken for Gram stain and KOH wet mount (both of which later returned negative results). Over the course of the next 2 weeks, the colonies at the back of the optic stem and the infiltrates in the corneal stroma of the carrier graft started resolving \[[Figure 1i](#F1){ref-type="fig"} and [j](#F1){ref-type="fig"}\]. BCVA improved to 20/200. Cryopreserved amniotic membrane was applied subsequently to deal with a persistent 360° epithelial defect on the carrier graft \[[Figure 1k](#F1){ref-type="fig"}\]. The patient remained stable for the next month with healing of the epithelial defect and resolution of the keratitis and endophthalmitis. Some inflammatory vitreous membranes persisted for which he was advised close follow-up. However, he missed a scheduled follow-up and 4 months later reported with decreased visual acuity when he was detected to have developed an inoperable closed funnel retinal detachment \[[Figure 1l](#F1){ref-type="fig"}\].

Discussion {#sec1-3}
==========

Barnes *et al*. reported fungal colonization of the ocular surface in K Pro eyes to be approximately 10%, with yeast (*Candida parapsilosis*) being the most common organism.\[[@ref5]\] In their series, of the 5 eyes which developed fungal infections, 4 patients recovered vision better than or equal to their vision before the K Pro surgery. Chan and Holland in their series of 126 patients implanted with the Boston type 1 keratoprosthesis reported 5 cases of fungal keratitis of whom 2 patients retained their preinfection best vision while 2 patients recovered vision to within two lines of their preinfection best visual acuity.\[[@ref8]\]

Experience from developing countries like India has however been less encouraging. Jain *et al*.,\[[@ref6]\] reported 2 cases of fungal keratitis and endophthalmitis where one eye was eviscerated and the other lost potential for useful vision. The case reported here also had a poor outcome in spite of aggressive management and initial resolution. Although we could not identify the causative fungus, the fluffy mulberry like colonies seen on the stem of the Auro K Pro appeared to resemble the clinical description of Candida deposits described by Barnes *et al*.,\[[@ref5]\] on the soft contact lens covering the keratoprosthesis. *C. parapsilosis* in particular has been shown to have an increased propensity to adhere to prosthetic materials.\[[@ref9]\] The presence of onychomycosis also may have been a predisposing factor as Candida and nondermatophytic molds are frequently the causative agents of fingernail infections in tropics and areas with a hot and humid climate.\[[@ref10]\]

As previously reported by Jain *et al*.\[[@ref6]\] an interplay of environmental (e.g., hot and humid climate) and socioeconomic factors (predominant involvement in agricultural activities, delay in seeking medical care) may be responsible for the poorer final outcomes in patients implanted with keratoprosthesis in developing countries. Management protocols may hence need to be defined separately for these areas. Primary implantation of a keratoprosthesis device perhaps needs to be avoided altogether. Topical povidone-iodine wash once a month,\[[@ref11]\] and prophylaxis in the form of short bursts of antifungals for 1 week every month as a routine part of the postoperative management protocol, are areas which need to be evaluated more extensively.
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